Measuring the Shield
Vaccine efficacy quantifies how well a vaccine protects against disease in a controlled clinical trial. The gold standard is the randomized, placebo-controlled, double-blind trial: participants are randomly assigned to receive the vaccine or a placebo, and neither they nor the investigators know which they received. By comparing disease rates between the two groups, researchers can isolate the vaccine's protective effect from confounding factors.
The Arithmetic of Protection
Efficacy is calculated by a deceptively simple formula: VE = 1 - (ARV/ARP), where ARV and ARP are the attack rates in the vaccinated and placebo groups respectively. If 50 out of 15,000 vaccinated participants get sick compared to 150 out of 15,000 placebo recipients, VE = 1 - (50/150) = 66.7%. But this single number hides important nuances: efficacy against infection may differ from efficacy against severe disease or death, and it may vary by age, sex, and time since vaccination.
Sample Size and Statistical Power
Designing a vaccine trial requires careful calculation of the sample size needed to detect a meaningful efficacy signal. The key drivers are the expected true efficacy, the disease incidence in the placebo group, the desired confidence level, and the minimum detectable efficacy. Lower disease incidence means more participants are needed because fewer total events occur. The COVID-19 trials of 2020 enrolled 30,000-44,000 participants each, powered to detect efficacy above 30% with 95% confidence.
From Trial to Real World
Clinical trial efficacy represents vaccine performance under ideal conditions. Real-world effectiveness is typically lower due to factors like imperfect cold chain storage, varying immune responses across diverse populations, waning immunity over time, and viral evolution. Post-licensure surveillance studies track effectiveness continuously, informing decisions about booster doses, updated formulations, and vaccination schedules. The gap between efficacy and effectiveness varies by vaccine but is a critical consideration for public health planning.